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Abstract 
Most genome-wide association studies are based on samples of European descent. We assess 
whether the genetic determinants of blood lipids, a major cardiovascular risk factor, are shared across 
populations. Genetic correlations for lipids between European-ancestry and Asian cohorts are not 
significantly different from 1. A genetic risk score based on LDL-cholesterol-associated loci has 
consistent effects on serum levels in samples from the UK, Uganda and Greece (r=0.23-0.28, p<1.9x10-
14). Overall, there is evidence of reproducibility for ~75% of the major lipid loci from European 
discovery studies, except triglyceride loci in the Ugandan samples (10% of loci). Individual transferable 
loci are identified using trans-ethnic colocalization. Ten of fourteen loci not transferable to the 
Ugandan population have pleiotropic associations with BMI in Europeans; none of the transferable 
loci do. The non-transferable loci might affect lipids by modifying food intake in environments rich in 
certain nutrients, which suggests an important role for gene-environment interactions.  
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Introduction	
Genome-wide association studies (GWAS) have been very successful in identifying genetic variants 
linked to cardiovascular disease (CVD) and to cardiometabolic traits1. Due to the improving predictive 
accuracy of these variants, genetic risk prediction could soon be implemented in clinical settings2,3. 
However, the majority of samples included in these genome “white” association studies were British 
or US-Americans with European ancestry4,5 which does not accurately represent the ethnically and 
ancestrally diverse populations of these nations. Moreover, three quarters of CVD-associated deaths 
occur in low- and middle-income countries where incidences are rising6. Consequently, it is important 
to determine whether cardiometabolic loci are transferable to other populations.  
Previous research assessed the effects of different allele frequencies and linkage disequilibrium (LD) 
on genetic associations across ancestry groups7. Here we ask the fundamental question whether 
causal variants for blood lipids, a major cardiovascular risk factor, are shared across populations. 
Heterogeneity in effects of variants could result from epistasis or gene-environment interactions. 
However, the causal variants are usually unknown. The differences in LD structure between 
populations make it difficult to compare the observed associations between ancestry groups because 
the effect of a variant depends on its correlation with the causal variant(s)7. Differences in allele 
frequency also impact the power to detect associations in other ancestry groups.  
We employ several strategies which account for these effects and do not require knowledge of the 
specific causal variants to quantify the extent to which genetic variants affecting lipid biomarkers are 
shared between individuals from Europe/North America, Asia, and Africa. We assess the 
transferability of individual signals and compare association patterns across the genome using data 
from the African Partnership for Chronic Disease Research – Uganda (APCDR-Uganda, N=6,407)8, 
China Kadoorie Biobank (CKB, N=21,295)9, the Hellenic Isolated Cohorts (HELIC-MANOLIS, N=1,641 
and HELIC-Pomak, N=1,945)10,11, and the UK Household Longitudinal Study (UKHLS, N=9,961)12. We 
also use summary statistics from Biobank Japan (BBJ, N=162,255)13 and the Global Lipid Genetics 
Consortium (European ancestry, GLGC2013 N=188,577, GLGC2017 N=237,050)14,15. We find evidence 
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for extensive sharing of genetic variants that affect levels of HDL- and LDL-cholesterol and triglycerides 
between individuals with European ancestry and samples from China, Japan and Greek population 
isolates. We estimate that about three quarters of major lipid loci are reproducible. Using trans-ethnic 
colocalization, we show that many established loci for triglycerides do not affect levels of this 
biomarker in Ugandan samples, however. Ten out of fourteen of the lipid loci that were not 
transferable to the Ugandan samples had pleiotropic associations with BMI in European ancestry 
samples. None of the transferable loci were linked to BMI. This could suggest an important role of 
environmental factors in modifying which genetic variants affect lipid levels. 
 
 
Results 
Reproducibility of established lipid loci  
We assessed rates at which established lipid-associated variants were reproducible in other 
populations. We selected major lipid loci, i.e. those with lipid associations at p<10-100 based on a score 
test in the largest European ancestry GWAS. In this context, reproducibility was operationalised as at 
least one variant from the credible set being associated at p<10-3 based on a score test with serum 
lipid levels in the target study. We defined the credible set as variants correlated at r2>0.6 with the 
lead SNP from the European discovery study. Correlation was estimated from the 1000 Genomes 
Project samples with European ancestry. As a benchmark, we also assessed replication in a European 
ancestry study, UKHLS. We found evidence of transferability for 76.5% of major HDL loci in this study 
(Table 1). For the non-European groups rates ranged from 70.6 to 82.4%. Similar reproducibility rates 
were observed for LDL loci (61.5-76.9%). For major triglycerides (TG) loci, rates ranged from 78.9 to 
94.7%, except in APCDR-Uganda. Only 10.5% of the TG loci showed evidence of reproducibility in that 
sample. Rates for known loci with p³10-100 in the discovery set were generally below 10%. However, 
Biobank Japan, the largest study, exhibited markedly higher reproducibility rates for these loci than 
the other studies with 24.6-32.7%.  
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Trans-ethnic genetic correlations 
Trans-ethnic genetic correlations were estimated between the three largest studies, China Kadoorie 
Biobank, Biobank Japan and GLGC2013 (Figure 1). For GLGC2013 and BBJ, correlations were 0.999, 
0.778, 0.999 for HDL, LDL and TG, respectively. For GLGC2013 and CKB, correlations were 0.999, 0.959, 
0.961 for HDL, LDL and TG, respectively. None of the estimates were significantly different from 1 
(Supplementary Table 1). We also compared associations across lipid biomarkers. This consistently 
showed negative genetic correlations between TG associations and HDL associations, with estimates 
ranging from rgen=-0.48 to rgen=-0.86.  
 
Genetic risk scores 
In order to assess patterns of sharing of risk alleles for the smaller studies, we constructed genetic risk 
scores (GRS) based on the established lipid loci from discovery studies with European-ancestry and 
validated the score associations with serum levels of HDL, LDL and TG in HELIC, APCDR-Uganda, CKB 
and also UKHLS as a benchmark (Figure 2). All genetic scores were significantly associated with their 
respective target lipid in the three European samples with largely consistent correlation coefficients 
and mutually overlapping 95% confidence intervals (CIs) (Table 2). For HDL, LDL and TG, the estimated 
correlation coefficients ranged from 0.27-0.28, 0.23-0.28  and 0.20-0.24, respectively. In APCDR-
Uganda, the strongest association was observed for LDL (r=0.28, SE=0.01, p=1.9x10-107 based on a 
mixed model score test). The HDL association was attenuated compared to the European ancestry 
samples (r=0.12, SE=0.01, p=6.1x10-22). The effect of the TG score was markedly weaker (r=0.06, 
SE=0.01, p=4.5x10-7). For CKB, the HDL GRS had a correlation of r=0.18 (SE=0.02, p=1.4x10-22) and the 
LDL GRS of r=0.20 (SE=0.02, p=32x10-26) while the triglyceride GRS showed a stronger attenuation 
relative to UKHLS with r=0.14 (SE=0.02, p=3.8x10-12). We also assessed associations between a given 
score and levels of each of the other lipid biomarkers (Supplementary Table 2). In line with the trans-
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ethnic genetic correlation results, we observed inverse associations between the HDL score and TG 
levels and vice versa in all studies, except APCDR-Uganda.  
 
Trans-ethnic colocalization 
Differences in LD structure, MAF and sample size make it difficult to assess the transferability of 
individual loci. Therefore, we propose a new strategy to assess evidence for shared causal variants 
between two populations: trans-ethnic colocalization. For this we re-purposed a method that was 
originally developed for colocalization of GWAS and eQTL results: Joint Likelihood Mapping (JLIM)16. 
In order to assess its performance for GWAS results from samples with different ancestry, we carried 
out a simulation study. UK Biobank (UKB) was used as a reference with European ancestry and 
compared to CKB and APCDR-Uganda. In order to derive an upper boundary for the power, we 
compared UKB to the ancestry-matched UKHLS set. Phenotypes were simulated. Effect size estimates 
were varied between 0.10 and 0.25 in order to represent a range similar to that observed for major 
lipid loci15. In the simulations of distinct causal variants in the non-European and the reference group, 
the frequencies of false positives were as expected close to 0.05 (Supplementary Table 3, 
Supplementary Figure 1). The power to detect shared associations  for betas of 0.25 was 73.1% for 
APCDR-Uganda, 93.1% for CKB and 0.89 for UKHLS (Figure 3). To investigate whether the lower power 
for APCDR-Uganda could be due to its smaller sample size, we reran the analyses for CKB using a 
random subset of samples matching the sample size of APCDR-Uganda. For effect sizes less than 0.2, 
the results from this analysis revealed decreased detection power relative to the full CKB set but still 
consistently higher than APCDR-Uganda.  This suggests that the power of this trans-ethnic 
colocalization method decreases somewhat with greater genetic distance between the populations 
that are compared.  
We applied trans-ethnic colocalization for established lipid loci to each study with UKHLS as the 
reference. There was evidence for significant (pjlim<0.05 based on a permutation test) colocalization 
with at least one of the target studies for about half of the major lipid loci (Supplementary Table 4). 
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For several of the major TG loci, such as 8q24.13, strong evidence of transferability to the Asian studies 
was observed whilst there was no evidence of association in APCDR-Uganda. Figure 4 shows the 
regional association plots of this locus for each data set as an example to demonstrate that differences 
in LD and frequencies lead to different association patterns. As colocalization can account for such 
differences, the result from the analysis comparing the European and Asian studies was nevertheless 
statistically significant (p < 0.001).  
We compared major lipid loci that showed evidence of transferability to APCDR-Uganda with those 
that did not. The proximal genes of transferable loci were enriched for lipid pathways including 
lipoprotein metabolism, lipid digestion mobilisation and transport, chylomicron-mediated lipid 
transport and metabolism of lipids and lipoproteins. The proximal genes of the non-transferable loci 
were enriched for several other pathways in addition to lipid metabolism, including SHP2 signalling, 
ABV3 integrin pathway, cytokine signalling in immune system, cytokine-cytokine receptor interaction 
and transmembrane transport of small molecules (Supplementary Figures 2 and 3). We also assessed 
the associations of these loci with BMI in samples with European ancestry using publicly available 
summary statistics from the GIANT consortium17 (N³484,680) (Table 3). Ten of the fourteen non-
transferable lipid loci had pleiotropic associations with BMI at a Bonferroni-adjusted threshold of 
p<0.0024. None of the seven transferable lipid loci were associated with BMI.  
 
Discussion 
Recent efforts to increase global diversity in genetics studies have been vital, enabling this 
comprehensive cross-population comparison of genetic associations with blood lipids. We provide 
evidence for extensive sharing of genetic variants that affect levels of HDL- and LDL-cholesterol and 
triglycerides between individuals with European ancestry and samples from China, Japan and Greek 
population isolates. We estimated that about three quarters of major lipid loci are reproducible. This 
was highly consistent across all studies except for triglyceride loci in APCDR-Uganda. None of the 
estimates of trans-ethnic genetic correlations between European, Chinese and Japanese samples were 
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significantly different from 1. All GRS associations in the two Greek isolated populations were highly 
consistent with those in the UK samples (correlations ranged from 0.27-0.28, 0.23-0.28  and 0.20-0.24, 
for HDL, LDL and TG, respectively, in these studies). Associations of genetic risk scores for LDL were 
not attenuated in the Ugandan population compared to the UK samples (r=0.28, SE=0.01, p=1.9x10-
107 based on a score test). 
Previous studies that compared the direction of effect of established loci or assessed associations of 
genetic risk scores reported differing degrees of consistency18–29. However, most of them were 
conducted in American samples with diverse ancestry, had smaller sample sizes and applied a single-
variant look-up or GRS for a limited number of genetic variants. The high degree of consistency for 
cholesterol biomarkers we observed also contrasts with previously reported trans-ethnic genetic 
correlations for other traits, such as major depression, rheumatoid arthritis, or type 2 diabetes, which 
were substantially different from 130,31. In a recent application using data from individuals with 
European and Asian ancestry from the UK and USA, the average genetic correlation across multiple 
traits was 0.55 (SE = 0.14) for GERA and 0.54 (SE=0.18) for UK Biobank32.  
As a limitation of our study, we did not adjust for use of lipid-lowering medication. This could in 
principle cause a small downward bias for the genetic effect estimates. However, few of the 
participants of the Ugandan and Chinese studies used lipid-lowering drugs. So this is unlikely to have 
an effect on the main conclusions of this work.  
Differences in LD structure, MAF and sample size make it difficult to assess the transferability of 
individual loci. We therefore propose a new approach: trans-ethnic colocalization. Simulations 
showed consistent control of type I error rates as well as power greater than 80% to detect shared 
associations between samples with European and Chinese ancestry for SNP effects greater or equal 
to 0.15. However, power was decreased for comparisons between samples from APCDR-Uganda and 
UK Biobank (51.5-73.1%). Hence, for the current implementation non-significant colocalization should 
not be considered as definitive evidence for the absence of shared causal variants when comparing 
African and European samples. Future work should address this through better modelling of the LD 
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structure. Moreover, for many of the major lipid loci, more than one independent association signal 
was identified in discovery GWASs15. When these are located in close proximity to each other, they 
can interfere with the trans-ethnic colocalization analysis because JLIM assumes a single causal 
variant. Therefore, future work should extend this approach to accommodate loci harbouring multiple 
causal variants.  
Using trans-ethnic colocalization, we showed that many established loci for triglycerides did not affect 
levels of this biomarker in Ugandan samples. This included loci associated at genome-wide significance 
in all the other studies, such as GCKR at 2p23.3 or LPL at 8p21.3. The genetic risk score for triglycerides 
had a weak effect on measured levels in APCDR-Uganda. This is unlikely to be an artefact of unreliable 
measurement: triglyceride levels had a heritable component in this sample (SNP heritability of  0.25, 
SE=0.058) and there were genome-wide significant associations. It is also unlikely that this can be 
explained purely by differences in LD and MAF because they would affect the analyses of the other 
two lipid biomarkers as well. Instead these discrepancies could be caused by gene-environment 
interactions. Ten out of fourteen of the lipid loci that were not transferable to the Ugandan samples 
had pleiotropic associations with BMI in European ancestry samples while none of the transferable 
loci were linked to BMI. It is possible that the non-transferable variants affect the amount of food 
intake with downstream consequences for lipid levels. This might require an environment offering 
diets that are rich in certain nutrients. While the proximal genes for transferable loci were almost 
exclusively linked to pathways of lipid metabolism, the ones for non-transferable loci were involved 
in diverse pathways which is in line with hypothesis. An alternative explanation could be that the non-
transferable loci are involved in metabolising nutrients given a particular diet that is not common in 
Uganda with downstream consequences for weight.  
Overall, this could suggest an important role of environmental factors in modifying which genetic 
variants affect lipid levels. Studying the causes for discordant loci between groups has promise to 
further elucidate the biological mechanisms of lipid regulation and other complex traits. Applying 
genetic risk prediction within clinical settings is receiving increasing attention. Our findings 
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demonstrate that  the transferability of genetic associations across different ancestry groups and 
environmental settings should be assessed comprehensively for medically relevant traits. This is 
important in order to ensure that health benefits of precision medicine are widely shared within and 
across populations. Ongoing programs in underrepresented countries33, such as the Human 
Hereditary and Health in Africa Initiative34, and programs focussing on underrepresented groups, such 
as PAGE35, All of Us36, or East London Genes and Health37, could provide the basis for this. 
 
 
Methods 
Data resources 
We included data from the Global Lipid Genetics Consortium (European ancestry samples only, GLGC), 
The UK Household Longitudinal Study (UKHLS), two isolated populations from the Greece Hellenic 
Isolated Cohorts (HELIC) , a rural West Ugandan population from the African Partnership for Chronic 
Disease Research (APCDR-Uganda) study, China Kadoorie Biobank (CBK), and Biobank Japan (BBJ). Raw 
genotype and phenotype data were available for UKHLS, APCDR-Uganda, CKB, HELIC-MANOLIS, and 
HELIC-Pomak. All participants provided written informed consent and each study obtained approval 
from ethical review boards. The APCDR-Uganda study was approved by the Uganda Virus Research 
Institute, Science and Ethics Committee (Ref. GC/127/10/10/25), the Uganda National Council for 
Science and Technology (Ref. HS 870), and the U.K. National Research Ethics Service, Research Ethics 
Committee (Ref. 11/H0305/5). The HELIC study was approved by the Harokopio University Bioethics 
Committee. The UKHLS has been approved by the University of Essex Ethics Committee and the nurse 
data collection by the National Research Ethics Service (10/H0604/2). For CKB, central ethics approvals 
were obtained from Oxford University, and the China National CDC. In addition, approvals were also 
obtained from institutional research boards at the local CDCs in the 10 regions. BBJ approved by the 
ethics committees of RIKEN Center for Integrative Medical Sciences and the Institute of Medical 
Sciences, the University of Tokyo. Our analyses were based on summary statistics for BBJ and GLGC. 
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The details of genotyping, QC and imputation for all studies are summarised in Supplementary Table 
5. Descriptive information about the sample sets is provided in Supplementary Table 6. Details of the 
quality control, imputation, genome-wide association analyses and ethical approval have also been 
previously described for GLGC14, BBJ13, HELIC10, APCDR-Uganda8 and UKHLS12. Each study confirmed 
sample ethnicity through PCA which rules out sample overlap between studies. 
For CKB, 102,783 participants were genotyped using 2 custom-designed Affymetrix Axiom® arrays 
including up to 803K variants, optimized for genome-wide coverage in Chinese populations. Stringent 
quality control included SNP call rate >0.98, plate effect P>10-6, batch effect P>10-6, HWE P>10-6 
(combined 10df χ2 test from 10 regions), biallelic, MAF difference from 1KGP EAS < 0.2, sample call 
rate >0.95, heterozygosity <mean+3SD, no chrXY aneuploidy, genetically-determined sex concordant 
with database, resulting in genotypes for 532,415 variants present on both array versions. Imputation 
into the 1,000 Genomes Phase 3 reference (EAS MAF>0) using SHAPEIT version 3 and IMPUTE version 
4 yielded genotypes for 10,276,633 variants with MAF >0.005 and info >0.3. 
In CKB, lipid levels were regressed against eight principle components, region, age, age2, sex, and - for 
LDL and TG - fasting time2 for the single SNP association analysis. For CKB, PCs were included in both 
single SNP and PRS association analyses to improve inflation. Recruitment for CKB occurred at 10 
different rural and urban locations across China leading to somewhat increased population structure. 
The resulting inflation estimates lambda after PC adjustment were 1.063, 1.050, and 1.053 for HDL, 
LDL and TG, respectively. LDL levels were derived using the Friedewald formula. After rank-based 
inverse normal transformation, the residuals were used as the outcomes in the genetic association 
analyses using linear regression. Associations were carried out within a mixed model framework using 
BOLT-LMM38.  
The single SNP association analysis for APCDR-Uganda was carried out within a mixed model 
framework using GEMMA39. Rank-based inverse normal transformation was applied to the lipid 
biomarkers after adjusting for age and gender. For Uganda, the inflation estimates lambda were 1.000, 
1.004, and 1.005 for HDL, LDL and TG, respectively.   
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Established lipid loci  
A list of established lipid-associated loci was extracted from the latest Global Lipid Genetics 
Consortium (GLGC2017) publication15 reporting 444 independent variants in 250 loci  
associated at genome-wide significance with HDL, LDL, and triglyceride levels. We excluded three LDL 
variants where the association was not primarily driven by the samples with European ancestry. We 
assessed evidence for transferability of the loci, applied trans-ethnic colocalization and used them to 
construct genetic risk scores. 
 
Reproducibility of established lipid loci  
We assessed evidence that these established lipid signals generalise to other populations. For loci 
harbouring multiple signals, we only kept the most strongly associated variant. Out of the 444 loci, 
this left 170 HDL, 135 LDL and 136 TG variants. We distinguished major loci, i.e. those with p<10-100 
based on a score test in GLGC2017. For each lead SNP we identified all variants in LD (r2>0.6) based 
on the European ancestry 1000 Genomes data. We assessed whether the lead or any of the correlated 
variants, henceforth called credible set, displayed evidence of association in the target study. If this 
was not the case, we tested whether there was any other variant with evidence of association within 
a 50Kb window. We used a p-value threshold of p<10-3 based on a score test. This threshold was 
derived by computing the minimum p-value in 1000 random windows of 50Kb for each study. Less 
than 5% of random windows had a minimum p<10-3 for the non-European ancestry studies. While this 
p-value threshold might not be appropriate to provide conclusive evidence of reproducibility for 
individual loci, we used this to test evidence of reproducibility across sets of loci. These analyses 
excluded the HELIC studies because the smaller sample size makes it difficult to differentiate between 
lack of power and lack of reproducibility. 
 
Trans-ethnic genetic correlations 
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We used the popcorn software30 to estimate trans-ethnic genetic correlations between studies while 
accounting for differences in LD structure. This provides an indication of the correlation of causal-
variant effect sizes across the genome at SNPs common in both populations. Variant LD scores were 
estimated for ancestry-matched 1000 Genomes v3 data for each study combination. The estimation 
of LD scores failed for chromosome 6 for some groups. We therefore left out the major 
histocompatibility complex (MHC) region (positions 28,477,797 to 33,448,354) from chromosome 6 
from all comparisons. Variants with imputation accuracy r2<0.8 or MAF<0.01 were excluded. Popcorn 
did not converge for any of the studies with less than 20,000 samples. Therefore, results are presented 
for comparisons between GLGC2013, CKB and BBJ. We estimated effect rather than impact 
correlations. We used a Bonferroni correction to adjust for multiple testing of three traits with each 
other (p<0.05/9=0.0056). 
 
Genetic risk scores  
As it was not possible to compute trans-ethnic genetic correlations for UKHLS, the HELIC cohorts, and 
APCDR-Uganda, we created genetic risk scores based on the established lipid loci and assessed their 
associations with serum lipid levels in these studies. We also tested the associations of GRS in CKB as 
raw data were available for this study as well. Age and sex were adjusted for by regressing them on 
the lipid biomarker values and using the residuals as outcomes for subsequent analyses. For CKB, we 
additionally adjusted for 20 PCs and region covariates in order to ensure population structure was 
accounted for. To ensure values are normally distributed, we used rank-based inverse normal 
transformation for all biomarkers and data sets which involves ordering values first and then assigning 
them to expected normal values. To make sure GRS were comparable across studies, we excluded 
variants that were absent, rare (MAF<0.01) or badly imputed (r2<0.8) in any of the studies and variants 
that had different alleles from those in the GLGC. The variant with larger discovery p-value from each 
correlated pair of SNPs (r2>0.1) was also removed. These filters were applied based on each, UKHLS, 
HELIC, and APCDR-Uganda and then the intersection of variants was carried forward to generate GRS. 
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Out of the 444 loci, this left 120, 103 and 101 variants for HDL, LDL and TG, respectively 
(Supplementary Table 7). We created trait-specific weighted GRS. The β-regression coefficients from 
SNP-trait associations in GLGC201715 were used as weights. All lipid biomarkers and scores were scaled 
to mean=0 and standard deviation=1 for each study, so that the regression coefficients represent 
estimates of the correlation between scores and lipid biomarkers.  
 We carried out association analyses between each genetic risk score and each lipid biomarkers using 
a linear mixed model with random polygenic effect implemented in GEMMA39 in order to account for 
relatedness and population structure. For CKB, we used BOLT-LMM because it is efficient for large 
samples. We used a Bonferroni correction to adjust for multiple testing of three GRS with three 
different lipid biomarker outcomes (p<0.05/9=0.0056 for the score test).  
 
Trans-ethnic colocalization 
Differences in allele frequency, LD structure and sample size make it difficult to assess whether a given 
GWAS hit are transferable to samples with different ancestries. Therefore, we applied trans-ethnic 
colocalization. Colocalization methods test whether the associations in two studies can be explained 
by the same underlying signal even if the specific causal variant is unknown. The joint likelihood 
mapping (JLIM) statistic was developed by Chun and colleagues to estimate the posterior probabilities 
for colocalization between GWAS and eQTL signals and compare them to probabilities of distinct 
causal variants16: 
  
 
JLIM explicitly accounts for LD structure. Therefore, we assessed whether it is suitable for trans-ethnic 
colocalization. For the reference sample set, it was possible to use genome-wide summary statistics 
𝑖 SNP 𝑚∗	lead SNP 𝐿&(𝑖) likelihood of SNP i being causal for trait 1 𝐿)(𝑖) likelihood of SNP i being causal for trait 2 𝑁+&(𝑖), 𝑁+)(𝑖) sets of SNPs in LD with i 𝜃 LD threshold 
𝛬 = / 𝐿&(𝑖) × log 𝐿&(𝑖)𝐿)(𝑖)max7∉9:;(<) 𝐿&(𝑖)𝐿)(𝑗)<∈9:?(@∗)  (1) 
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for the analysis. For this set, LD scores were estimated using a subset of samples from the 1000 
Genomes Project v3 that had matching ancestry to that study. The second sample set needed raw 
genotype data and LD was estimated directly for these samples. JLIM assumes only one causal variant 
within a region in each study. We therefore used small windows of 50Kb for each known locus to 
minimise the risk of interference from additional association signals. Distinct causal variants were 
defined by separation in LD space by r2³0.8 from each other. We excluded loci within the MHC region 
due to its complex LD structure. We used a significance threshold of p<0.05 given the evidence of 
association of the established lipid loci in Europeans and the overall evidence for shared causal genetic 
architecture across populations for most lipid traits from our other analyses. We compared each 
target study to UKHLS because of the study's high level of homogeneity in terms of ancestry, 
biomarker quantification and study design.   
 
Simulation  
To test the power of trans-ethnic colocalization to detect associations shared between pairs of 
populations with different ancestry, we ran JLIM on two sets of simulated traits with realistic effect 
size and environmental noise level. The first set of simulations used the same causal variant in both 
populations, whereas the second set of simulations used discordant causal variants. Causal variants 
were selected using the sample function in R, corresponding to a uniform random draw from the 
entire chromosome. We sampled 10,000 randomly chosen biallelic variants with MAF>0.05 and 
simulated random phenotypes in UKHLS, CKB, APCDR-Uganda and 50,000 individuals with British 
ancestry from UK Biobank as the reference set. For UK Biobank we applied the QC and used the 
ancestry assignment provided by Bycroft et al40. UKHLS was included as an ancestry-matched set in 
order to derive an upper limit estimate of the power. For each data set relatives were excluded. We 
also sub-sampled CKB to match the number of individuals in APCDR-Uganda in order to test whether 
the difference in performance was due to ancestry or sample size. We used a simple linear model to 
generate the phenotype for each individual i: 
(2) 
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𝑦< = 𝛽 ∗ (𝑥< − 1) + 𝜂< 
where y is the phenotype value, b is the effect size, x is the number of the alternate alleles carried at 
the locus and 𝜂<~𝑁(0, 𝜎)), where s2 is the variance of the environmental noise and CovN𝜂<, 𝜂7O = 0. 
We tested effect size estimate beta from 0.10, 0.15, 0.20 and 0.25 in order to represent a range similar 
to that observed for the major lipid loci15. We used s2 = 1 to match the trait variances of the 
standardised phenotypes.  
 
Comparison of transferable loci with non-transferable loci  
We assessed whether there are any systematic differences between loci that are shared between 
European ancestry samples and APCDR-Uganda and loci that are not.  We identified all loci with 
evidence of reproducibility based on the above definition that also had significant (p<0.05) 
colocalization based on a permutation test. We only kept one variant per region. We contrasted them 
with loci where none of the evidence suggested generalisation: p>0.05 for colocalization or missing 
result due to failed convergence, no variant with a lipid association at p<10-3 in the region and the lead 
variant from the discovery study was not rare in APCDR-Uganda. We identified the nearest protein 
coding gene for each locus and carried out pathway analyses for the two sets using FUMA41. We also 
assessed the associations of the lead variants with body mass index (BMI) in European ancestry 
samples using results from a meta-analysis between the GIANT consortium and UK Biobank17. We 
used a Bonferroni adjusted p-value threshold. 
 
Data availability  
The UKHLS EGA accession number is EGAD00010000918. Genotype-phenotype data access for UKHLS 
is available by application to Metadac (www.metadac.ac.uk). Summary statistics for GLGC 
(http://csg.sph.umich.edu/abecasis/public/) and Biobank Japan (http://jenger.riken.jp/en/) are 
publicly available. The HELIC genotype and WGS datasets have been deposited to the European 
Genome-phenome Archive (https://www.ebi.ac.uk/ega/home): EGAD00010000518; 
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EGAD00010000522; EGAD00010000610; EGAD00001001636, EGAD00001001637. The APCDR 
committees are responsible for curation, storage, and sharing of the APCDR-Uganda data under 
managed access. The array and sequence data have been deposited at the European Genome-
phenome Archive (EGA, http://www.ebi.ac.uk/ega/, study accession number EGAS00001000545, 
datasets EGAS00001001558 and EGAD00001001639 respectively) and can be requested through 
datasharing@sanger.ac.uk. Requests for access to phenotype data and summary statistics may be 
directed to data@apcdr.org. This is restricted to research-related purposes. Uploading and 
sharing of individual genetic data from CKB are subject to restrictions according to the Interim 
Measures for the Administration of Human Genetic Resources administered by the Human Genetic 
Resources Administration of China (HGRAC). Summary data including allele frequencies and GWAS 
summary statistics are available on application. This is restricted to research-related purposes. 
Other individual-level CKB data are available through www.ckbiobank.org, subject to completion of a 
Material Transfer Agreement, either through Open Access or on application. CKB data access is subject 
to oversight by an independent Data Access Committee. 
 
Code availability  
Our code to run trans-ethnic colocalization using JLIM and simulations is available through github: 
https://github.com/KarolineKuchenbaecker/TEColoc  
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Figure legends 
Figure 1. Trans-ethnic genetic correlations rgen for associations with high-density lipoprotein (HDL), 
low-density lipoprotein (LDL) cholesterol and triglycerides (TG). a) shows the comparison of 
GLGC2013 (European) and Biobank Japan (BBJ), b) GLGC2013 and China Kadoorie Biobank (CKB) and 
c) BBJ and CKB. The values on the diagonal show correlations for matched lipid markers in the two 
studies. The off-diagonal values show genetic correlations across lipid biomarkers (e.g. HDL vs TG). 
Colours correspond to the direction and strength of rgen. 
 
Figure 2. Associations of genetic risk scores based on established lipid-associated loci with serum 
levels of high-density lipoprotein (HDL), low-density lipoprotein (LDL) cholesterol and triglycerides 
(TG) in a) UKHLS, b) HELIC-MANOLIS, c) HELIC-Pomak, d) APCDR-Uganda, e) CKB. Estimates are given 
as correlation coefficients r with colours corresponding to the direction and strength of r. Stars 
indicate statistically significant associations based on a score test (p<0.0056). The values on the 
diagonal represent the strength of correlation of a GRS with its target lipid biomarker. The off-
diagonal elements show the strength of correlation of a GRS (e.g. TG) with the other lipid markers 
(e.g. HDL). 
 
Figure 3. Power of trans-ethnic colocalization to detect shared associations for different effect sizes 
(Beta). Based on a simulation study comparing 50,000 samples with European ancestry from UK 
Biobank to UKHLS, APCDR-Uganda ("UG"), and China Kadoorie Biobank ("CKB"). Additionally, China 
Kadoorie Biobank was downsampled to N=4597 ("CKB_4K") to match the sample size of APCDR-
Uganda. 
 
Figure 4. Regional plots for SNP associations with triglyceride levels at established triglyceride-
associated locus 8q24.13 for UKHLS, Biobank Japan (BBJ), APCDR-Uganda, and China Kadoorie 
Biobank (CKB) and p-value pjlim based on a permutation test for the trans-ethnic colocalization with 
UKHLS. Filling colour of the points corresponds to the strength of linkage disequilibrium (r2) of each 
variant with the lead variant rs2954029.  
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Tables 
Table 1.  Percentage of established lipid-associated loci with evidence of reproducibility in target 
studies. Only one SNP was kept for each locus with multiple associated variants in close proximity. 
Regions were defined as 25Kb either side of the lead variant. The credible set contains the reported 
lead variant and variants in LD (r2>0.6) with it. Results are shown separately for groups of loci by 
strength of association (whether p<10-100) in the discovery study (GLGC). There were 25, 16 and 27 
loci with p<10-100 based on a score test in GLGC for HDL, LDL, and TG, respectively. There were 212, 
171 and 158 loci with p³10-100 for HDL, LDL, and TG, respectively.  
P in GLGC: <10-100 ³10-100 
Study Trait n.s.* Region† Credible‡  n.s. * Region† Credible‡ 
UKHLS HDL 5.9  17.6  76.5   81.0  13.7   5.2  
 LDL 7.7 15.4 76.9   77.0 16.4   6.6 
 TG 0.0 5.3 94.7   82.1 14.5   3.4 
CKB HDL 11.8  5.9 82.4  71.2  16.4   12.4  
 LDL 7.7 30.8 61.5   83.6 7.4   9.0 
 TG 5.3 15.8 78.9   82.9 10.3   6.8 
BBJ HDL 11.8  11.8 76.5  47.7  19.6  32.7  
 LDL 7.7 30.8 61.5   64.8 10.7   24.6 
 TG 5.3 10.5 84.2   55.6 12.8 31.6 
APCDR- 
Uganda 
HDL 11.8  17.6 70.6  73.2  25.5    1.3   
LDL 23.1 7.7 69.2 73.8 24.6   1.6 
TG 42.1 47.4 10.5 79.5 17.1   3.4 
* No variant in the region associated in target set at p<10-3 
† No variant in the credible set associated in the target set at p<10-3 but an uncorrelated variant in 
the region is associated in target set at p<10-3 
‡ A variant in the credible set is associated in the target set at p<10-3  
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Table 2: Associations of genetic risk scores based on established lipid-associated loci and respective 
serum lipid levels in UKHLS, HELIC-MANOLIS, -Pomak, APCDR-Uganda, and CKB using a linear mixed 
model analysis. P-values are based on score tests. 
 Trait N   Correlation (SE*) Confidence 
interval 
P-value 
UKHLS     
 HDL 9706  0.285 (0.010) 0.265, 0.305 4.52x10-166  
 LDL 9767  0.274 (0.010) 0.254, 0.294 1.32x10-155  
 Triglycerides 9635  0.204 (0.010) 0.183, 0.223 9.62x10-87  
HELIC-MANOLIS     
 HDL 1186  0.279 (0.029) 0.222, 0.336 4.08x10-20  
 LDL 1186  0.229 (0.029) 0.172, 0.286 2.41x10-14  
 Triglycerides 1176  0.235 (0.030) 0.176, 0.294 4.52x10-14  
HELIC-Pomak     
 HDL 1078  0.268 (0.030) 0.209, 0.327 2.39x10-17  
 LDL 1075  0.290 (0.030) 0.231, 0.349 3.04x10-19  
 Triglycerides 1066  0.234 (0.030) 0.175, 0.293 2.00x10-13  
APCDR-Uganda     
 HDL 6407  0.121 (0.012) 0.098, 0.145 6.06x10-22  
 LDL 6407  0.280 (0.012) 0.257, 0.304 1.91x10-107  
 Triglycerides 6407  0.063 (0.013) 0.038, 0.089 4.46x10-7 
CKB     
 HDL 20810 0.180 (0.018) 0.145, 0.215 1.4x10-22 
 LDL 17662 0.198 (0.019) 0.161, 0.235 3.2x10-26 
 Triglycerides 20222 0.139 (0.020) 0.100, 0.178 3.8x10-12 
*SE=standard error 
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Table 3. Association of established lipid-associated loci with body mass index by whether the locus 
was transferable to APCDR-Uganda. BMI association results are based on N³484,680 samples from 
the meta-analysis between GIANT and UK Biobank17. Results are shown exclusively for loci where 
there was clear evidence for or against transferability to APCDR-Uganda (see Methods for more 
details). 
Transferable Trait rs-id Chr Position Annotation beta SE P-value 
no HDL rs11755393 6 34824636 UHRF1BP1 -0.025 0.002 9.8x10-48 
no HDL rs1178979 7 72856430 BAZ1B -0.010 0.002 3.1x10-6 
no HDL rs4731702 7 130433384 KLF14 0.008 0.002 3x10-7 
no HDL rs2954033 8 126493746 NSMCE2 -0.010 0.002 6.4x10-8 
no LDL rs4245791 2 44074431 ABCG8 0.002 0.002 0.22 
no LDL rs3846662 5 74651084 HMGCR 0.020 0.002 1.9x10-35 
no LDL rs2737229 8 116648565 TRPS1 0.014 0.002 1.9x10-15 
no LDL rs635634 9 136155000 IL6R 0.005 0.002 0.03 
no LDL rs2000999 16 72108093 HPR 0.011 0.002 8.6x10-8 
no TG rs1260326 2 27730940 GCKR -0.011 0.002 1.2x10-10 
no TG rs2943641 2 227093745 IRS1 0.006 0.002 5.8x10-4 
no TG rs6905288 6 43758873 VEGFA -0.010 0.002 1.9x10-9 
no TG rs11820589 11 116633862 APOA5 -0.003 0.003 0.41 
no TG rs58542926 19 19379549 TM6SF2 -0.003 0.003 0.33 
yes HDL rs643531 9 15296034 TTC39B 0.000 0.002 0.92 
yes HDL rs1800588 15 58723675 LIPC -0.002 0.002 0.25 
yes HDL rs3764261 16 56993324 CETP -0.002 0.002 0.39 
yes HDL rs16942887 16 67928042 PSKH1 -0.005 0.003 0.06 
yes LDL rs12740374 1 109817590 CELSR2 0.003 0.002 0.18 
yes LDL rs1367117 2 21263900 APOB -0.002 0.002 0.19 
yes LDL rs6511720 19 11202306 LDLR 0.006 0.003 0.03 
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Supplementary figures and tables 
 
 
 
Supplementary Figure 1: QQ-plots for the p-values based on a permutation test from the trans-ethnic 
colocalization for simulated traits with distinct causal variants in UK Biobank and A) CKB and B) APCDR-
Uganda C) UKHLS to provide an ancestry-matched control. Well-controlled type I errors manifest as a 
close match between the points and the diagonal line. 
 
 
 
 
 
  
A) B) 
C) 
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Supplementary Figure 2: Enrichment of canonical pathways (MsigDB c2) for genes proximal to 
established lipid-associated SNPs that A) replicate in APCDR-Uganda and B) do not replicate in APCDR-
Uganda 
A) 
B) 
 4 
 
A) B) 
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Supplementary Figure 3: Enrichment of GO biological processes (MsigDB c5) for genes proximal to established lipid-associated SNPs that A) replicate in 
APCDR-Uganda and B) do not replicate in APCDR-Uganda 
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Supplementary Table 1: Trans-ethnic genetic correlation estimates and p-values based on a Z-test 
whether the genetic correlation deviates from 1 for each lipid biomarker in one study with each lipid 
biomarkers in the other study 
biomarker correlation standard error p-value* 
GLGC2013 (European) – China Kadoorie Biobank 
HDL-HDL 0.999 - - 
LDL-LDL 0.778 0.300 0.460 
TG-TG 0.999 - - 
HDL - LDL 0.068 0.229 0.000 
HDL - TG -0.550 0.176 0.000 
LDL - HDL -0.238 0.143 0.000 
LDL - TG 0.473 0.155 0.001 
TG - HDL -0.741 0.162 0.000 
TG - LDL -0.226 0.195 0.000 
GLGC2013 (European) – Biobank Japan 
HDL-HDL 0.999 0.081 0.999 
LDL-LDL 0.959 0.138 0.765 
TG-TG 0.961 0.066 0.555 
HDL - LDL -0.055 0.097 0.000 
HDL - TG -0.592 0.130 0.000 
LDL - HDL -0.277 0.150 0.000 
LDL - TG 0.294 0.056 0.000 
TG - HDL -0.481 0.176 0.000 
TG - LDL -0.038 0.091 0.000 
China Kadoorie Biobank – Biobank Japan 
HDL-HDL 0.999 - - 
LDL-LDL 0.871 0.225 0.566 
TG-TG 0.999 - - 
HDL - LDL 0.085 0.141 0.000 
HDL - TG -0.618 0.151 0.000 
LDL - HDL 0.290 0.185 0.000 
LDL - TG 0.180 0.169 0.000 
TG - HDL -0.862 0.186 0.000 
TG - LDL -0.097 0.153 0.000 
* When the estimate is close to the boundary of 1, popcorn cannot compute the standard error and 
p-value 
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Supplementary Table 2: Associations of polygenic scores based on established lipid-associated loci 
and serum levels of each of the other lipid biomarkers in UKHLS, APCDR-Uganda, HELIC-MANOLIS, -
Pomak, and CKB using a linear mixed model analysis with a score test to derive the p-value. 
score - trait correlation SE (β) p-value 
UKHLS 
HDL - LDL -0.0526 1.01E-02 2.02E-07 
HDL - TG -0.0720 1.02E-02 1.63E-12 
LDL - HDL -0.0516 1.01E-02 3.97E-07 
LDL - TG 0.00845 1.02E-02 0.407 
TG - HDL -0.134 1.01E-02 1.67E-39 
TG - LDL 0.0117 1.01E-02 0.247 
APCDR-Uganda    
HDL - LDL -0.0149 1.25E-02 0.234 
HDL - TG -0.0144 1.25E-02 0.249 
LDL - HDL -0.0773 1.25E-02 6.75E-10 
LDL - TG 0.0422 1.25E-02 7.27E-04 
TG - HDL -0.00513 1.25E-02 0.681 
TG - LDL -0.0467 1.25E-02 1.86E-04 
HELIC-Pomak 
HDL - LDL -0.0722 3.09E-02 1.97E-02 
HDL - TG -0.128 3.10E-02 4.96E-05 
LDL - HDL -0.0608 3.18E-02 6.00E-02 
LDL - TG 0.00343 3.19E-02 0.918 
TG - HDL -0.157 3.05E-02 6.16E-07 
TG - LDL 0.0739 3.08E-02 1.70E-02 
HELIC-Manolis 
HDL - LDL 0.00919 2.96E-02 0.756 
HDL - TG -0.0936 3.01E-02 2.13E-03 
LDL - HDL -0.0229 2.97E-02 0.442 
LDL - TG -0.00136 3.03E-02 0.964 
TG - HDL -0.133 2.98E-02 1.25E-05 
TG - LDL -0.00163 2.98E-02 0.956 
CKB    
HDL - LDL -0.0082 0.0183 0.65 
HDL - TG -0.0667 0.0200 8.6E-04 
LDL - HDL -0.0287 0.0186 0.12 
LDL - TG -0.0144 0.0203 0.65 
TG - HDL -0.0604 0.0183 9.8E-04 
TG - LDL -0.0499 0.0183 6.5E-03 
 
 
 
  
 8 
Supplementary Table 3. Type I error rates from a simulation to assess the performance of trans-
ethnic colocalization when causal variants are not shared. Phenotypes were simulated 10,000 times 
for each study and different values of effect sizes. Trans-ethnic colocalization was run to compare 
each to a reference set of 50,000 samples with British ancestry from UK Biobank. CKB was also down-
sampled to match the sample size of APCDR-Uganda. 
 Study (N) APCDR-Uganda (4,597) 
UKHLS 
(9,150) 
CKB 
(72,473) 
CKB 
(4,597) 
Beta 
0.10 0.044 0.043 0.065 0.059 
0.15 0.040 0.057 0.050 0.050 
0.20 0.048 0.059 0.073 0.059 
0.25 0.048 0.050 0.052 0.045 
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Supplementary Table 4. P-value for the trans-ethnic colocalization based on a permutation test for the JLIM model for established lipid-
associated loci in UKHLS, China Kadoorie Biobank (CKB), Biobank Japan (BBJ) and APCDR-Uganda (UG). 
    GLGC  reproduciblea JLIM p-valueb 
rs-id chr position near gene MAF p-value Multic UKHLS CKB BBJ UG CKB BBJ UG 
HDL              
rs4660293 1 40028180 PABPC4 0.21 6.1E-36 distant uc ns cor ns 0.8 0.014 NA 
rs11755393 6 34824636 UHRF1BP1 0.36 4.2E-23 distant ns ns cor ns 0.035 0 NA 
rs1178979 7 72856430 BAZ1B 0.18 1.3E-26 near uc uc cor ns 0 0 NA 
rs4731702 7 130433384 KLF14 0.46 1.2E-35 distant ns cor cor ns 0.14 0.003 NA 
rs4841132 8 9183596 PPP1R3B 0.9 1.0E-123 no ns ns ns cor 0.99 0.24 0.16 
rs328 8 19819724 LPL 0.098 1.7E-316 near cor cor cor cor 0.21 0.005 0.62 
rs2954033 8 126493746 NSMCE2 0.72 3.0E-61 near cor cor cor ns 0.94 0.002 NA 
rs643531 9 15296034 TTC39B 0.88 3.8E-42 no ns ns uc uc NA NA NA 
rs2066714 9 107586753 ABCA1 0.15 3.6E-31 near uc cor cor uc 0.97 0.007 0.94 
rs1883025 9 107664301 ABCA1 0.26 2.1E-118 near uc cor cor uc 0.84 0.8 0.97 
rs2792751 10 113940329 GPAM 0.73 3.8E-21 near ns ns cor uc 0.002 0.002 NA 
rs7350481 11 116586283 APOA5 0.91 3.2E-100 distant cor cor cor uc 0 0 0.99 
rs964184 11 116648917 ZPR1 0.85 2.6E-217 near cor cor cor uc 1 1 1 
rs10468017 15 58678512 LIPC 0.27 1.8E-306 near cor cor cor cor 1 0.98 0.99 
rs1800588 15 58723675 LIPC 0.24 0 distant cor cor cor cor 0.007 0.009 0.017 
rs247616 16 56989590 CETP 0.31 0 near cor cor cor cor 0 0 0 
rs3764261 16 56993324 CETP 0.31 0 near cor cor cor cor 0 0 0 
rs34065661 16 56995935 CETP 0.005 5.6E-103 near uc uc uc cor 0 0 0 
rs16942887 16 67928042 PSKH1 0.13 9.8E-93 near ns ns cor cor 0.96 0.29 0.025 
rs72836561 17 41926126 CD300LG 0.028 8.1E-111 no uc uc uc ns NA NA NA 
rs7241918 18 47160953 LIPG 0.85 1.2E-104 distant cor cor cor ns 0.16 1 1 
rs116843064 19 8429323 ANGPTL4 0.02 4.8E-146 near uc ns ns uc NA NA NA 
rs769449 19 45410002 APOE 0.11 6.9E-129 near cor cor cor cor 0.009 0.02 0.95 
rs386000 19 54792761 LILRB2 0.22 1.1E-41 distant cor uc cor cor 0 1 0.71 
LDL              
rs11591147 1 55505647 PCSK9 0.015 0.0 near uc uc uc uc 0.94 0.64 0.92 
rs12740374 1 109817590 CELSR2 0.22 0.0 near cor cor cor cor 0 0 0 
 10 
rs1367117 2 21263900 APOB 0.28 3.6E-278 near cor cor cor cor 1 1 0 
rs541041 2 21294975 APOB 0.81 1.3E-287 distant cor uc uc cor 1 1 NA 
rs4245791 2 44074431 ABCG8 0.72 1.7E-120 near uc ns ns ns NA 0.81 0.99 
rs3846662 5 74651084 HMGCR 0.48 3.3E-128 near cor cor cor ns 0.002 0 1 
rs2737229 8 116648565 TRPS1 0.34 8.9E-15 distant cor ns cor ns 0.015 0.025 NA 
rs635634 9 136155000 IL6R 0.19 4.9E-109 near ns cor cor ns 0.96 0.97 NA 
rs2000999 16 72108093 HPR 0.2 4.0E-71 distant cor cor cor ns 1 0 1 
rs6511720 19 11202306 LDLR 0.11 0.0 near cor uc uc cor 0 NA 0 
rs28399654 19 45316588 BCAM 0.027 7.5E-232 distant cor uc uc cor 1 1 NA 
rs7412 19 45412079 APOE 0.075 0.0E+00 near cor cor cor cor 0 0 0 
Triglycerides              
rs10889353 1 63118196 DOCK7 0.33 6.4E-170 no cor cor cor uc 0 0 0.88 
rs676210 2 21231524 APOB 0.26 4.9E-118 near cor uc cor uc 1 1 1 
rs1260326 2 27730940 GCKR 0.63 0.0 near cor cor cor ns 0 NA NA 
rs2943641 2 227093745 IRS1 0.66 4.9E-33 no ns ns cor ns 0.006 NA 1 
rs6905288 6 43758873 VEGFA 0.59 9.0E-35 near cor ns cor ns 0 0 NA 
rs1178979 7 72856430 BAZ1B 0.18 1.5E-179 near cor cor cor ns 0 0 NA 
rs35332062 7 73012042 MLXIPL 0.12 5.2E-205 distant cor cor cor uc 0.99 1 NA 
rs326 8 19819439 LPL 0.3 0.0 near cor cor cor uc 0.91 0.91 0.72 
rs2954029 8 126490972 TRIB1 0.45 8.3E-205 near cor cor cor ns 0 0 1 
rs1883025 9 107664301 ABCA1 0.26 1.2E-13 no uc ns ns ns 1 0.001 NA 
rs7350481 11 116586283 APOA5 0.91 0.0 distant cor cor cor uc 0 0 0 
rs11820589 11 116633862 APOA5 0.066 4.4E-133 near cor uc uc ns 0 1 1 
rs2075291 11 116661392 APOA5 0.003 5.7E-65 near uc cor cor ns NA 1 NA 
rs10047462 11 116722041 SIK3 0.86 9.9E-180 near cor cor cor uc 0 0 1 
rs247616 16 56989590 CETP 0.31 2.4E-38 near ns ns cor cor 0.014 0.024 0.78 
rs116843064 19 8429323 ANGPTL4 0.02 4.2E-175 near uc ns ns ns NA NA NA 
rs58542926 19 19379549 TM6SF2 0.074 3.7E-125 no cor cor cor ns NA NA NA 
rs439401 19 45414451 APOE 0.63 2.7E-168 near cor cor cor uc 0.009 0.53 1 
a indicates whether any variant from the credible set (“cor”) or any uncorrelated variant within 50kb (“uc”) is associated with the target 
biomarker at p<10-3 in each of the target studies 
b p-value from the JLIM trans-ethnic colocalization analysis using UKHLS as the comparison set 
c indicates whether multiple independent hits have been reported within 50kb (“near”) or 1Mb (“distant”) 
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Supplementary Table 5: Summary of the genotyping, quality control, and imputation of each study 
study array QC criteria SNPs N SNPs 
genotyp
ed 
N SNPs 
after QC 
Reference 
panel 
imputation 
Imput
ation 
metho
d 
N 
SNPs 
impu
ted 
and 
QCe
d 
QC criteria samples N samples 
after QC 
UK 
Household 
Longitudina
l Study1 
HumanCo
reExome 
Hardy-Weinberg 
equilibrium p-value < 
1×10−4, call rate < 
98%, poor genotype 
clustering values 
(<0.4) 
538,448 525,314 
 
UK10K, 
1000 
Genomes 
v3 
SHAPE
IT, 
IMPUT
E2 
24,7
27,0
32 
call rate <98%, 
autosomal 
heterozygosity 
outliers (>3SD), 
gender 
mismatches, 
duplicates (PI_HAT 
> 0.9), non-
European ancestry 
9,962 (9798 for 
HDL,  9797 for 
LDL,  9807 for TG) 
African 
Partnership 
for Chronic 
Disease 
Research - 
Uganda2 
HumanO
mni2.5 
call rate <0.97, 
Hardy-Weinberg 
equilibrium  p<10-8 
2,369,3
82 
2,330,0
14 
1000G v3, 
1,978 
samples 
from 
Uganda 
SHAPE
IT, 
IMPUT
E2 
19,5
39,4
50 
call rate <97%, 
heterozygosity 
(>3SD), gender 
mismatch, 
IBD>0.90, ancestry 
outliers (none) 
6,407 (for all 
biomarkers) 
China 
Kadoorie 
Biobank3 
Custom 
Affymetri
x Axiom 
Array 
SNP call rate >0.98, 
plate effect P>10-6, 
batch effect P>10-6, 
HWE P>10-6 
(combined 10df χ2 
test from 10 
regions), biallelic, 
MAF difference from 
1KGP EAS < 0.2 
701K/83
0K, 
532,415 1000 
Genomes 
v3 
SHAPE
IT3 
and 
IMPUT
E4 
10,2
76,6
33 
sample call rate 
>0.95, 
heterozygosity 
<mean+3SD, no 
chrXY aneuploidy, 
genetically-
determined sex 
concordant with 
database 
21,295  (20,810 
for HDL, 17,662 
for LDL, 20,219 
for TG) 
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RIKEN 
Biobank 
Japan4 
HumanO
mniExpre
ss 
call rate < 0.99, 
minor allele 
frequency < 1%, 
Hardy–Weinberg 
equilibrium p≤ 
1.0×10−6 
~1M NA 1000 
Genomes v 
3 East 
Asians 
 
MACH, 
minim
ac 
6,10
8,95
3 
call rate <0.98, 
closely related 
individuals based 
on IBD, non–East 
Asian outliers 
identified by PCA 
together with 
HapMap samples 
 
162,255 (70,657  
for HDL, 72,866 
for LDL, 105,597 
for TG) 
 
Hellenic 
Isolated 
Cohorts5,6 
MANOLIS, 
Pomak 
Whole-
genome 
sequencin
g 
VQSR with a tranche 
threshold of 99.4%, 
call rate <99% 
 
NA NA NA NA 24,1
63,8
96 
sex checks, low 
concordance 
(π^<0:8) with chip 
data, duplicates, 
traces of 
contamination; 
checked but no 
exclusion 
necessary: depth, 
heterozygosity, 
transition/transver
sion (Ti/Tv) rate, 
missingness, 
ethnicity. 
 
1,641 (1632 for 
HDL, 1630 for 
LDL, 1632 for TG), 
1,945 (1915 for 
HDL, 1914 for 
LDL, 1916 for TG), 
Global 
Lipids 
Genetics 
Consortium
7 
23 studies 
GWAS 
arrays, 37 
Metaboch
ip 
study specific 196,710 
 
study 
specific 
HapMap MACH 2.6M study specific 188,577 
Global 
Lipids 
Genetics 
HumanEx
ome 
 NA 242,289 NA NA NA call rate, 
heterozygosity, sex 
discordance, GWAS 
discordance, 
237,050 
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Supplementary Table 6: Study description and mean levels of HDL-cholesterol, LDL-cholesterol and triglycerides (TG) in mmol/l 
study acronym population array N SNPs 
genotyped, 
imputed 
N 
samples 
 
%female mean 
age 
mean 
HDL 
mean 
LDL 
mean 
TG 
UK Household 
Longitudinal Study1 
UKHLS British HumanCoreExome 248K, 
26M 
 
9,962 44 52 1.55 3.02 1.81 
African Partnership 
for Chronic Disease 
Research - Uganda2 
APCDR-
Uganda 
Ugandan HumanOmni2.5 2.2M, 20M 6,407 56 34 1.02 2.05 1.18 
China Kadoorie 
Biobank3 
CKB 
 
Chinese Custom Affymetrix 
Axiom Array 
701K/830K,  
10M 
21,295 
 
62 60 1.37 2.19 1.69 
RIKEN Biobank 
Japan4 
BBJ 
 
Japanese HumanOmniExpress 6M 162,255 63 43 1.42 3.38 1.50 
Hellenic Isolated 
Cohorts5,6 
HELIC-
MANOLIS, -
Pomak 
 
Isolated 
Greek 
populations 
Whole-genome 
sequencing 
24M 
 
1,641, 
1,945 
42,34 62,45 1.28, 
1.18 
3.27, 
3.09 
1.61, 
1.58 
Global Lipids 
Genetics 
Consortium7 
GLGC2013 
(meta-
analysis) 
 
European 
ancestry 
23 studies GWAS 
arrays, 37 
Metabochip 
200K, 
2.5M 
188,577      
Global Lipids 
Genetics 
Consortium8 
GLGC2017 
(meta-
analysis) 
European 
ancestry 
HumanExome 242,289 237,050      
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Supplementary Table 7: SNPs used to create genetic risk scores for HDL-cholesterol, LDL-
cholesterol and triglycerides (TG) with reference alleles and weights. 
HDL   LDL   TG   
rs-id 
refer
ence 
weigh
t rs-id 
refer
ence weight rsid 
refer
ence 
weigh
t 
rs11553746 C 0.015 rs13379043 T -0.018 rs1011731 G -0.015 
rs2276853 G -0.015 rs12748152 C 0.031 rs900399 A -0.014 
rs28932178 T 0.02 rs12740374 G -0.16 rs10861661 A 0.019 
rs740363 G 0.014 rs676210 G -0.039 rs12748152 C 0.031 
rs622082 A -0.017 rs3756772 C 0.014 rs4846914 G -0.039 
rs2074158 T -0.02 rs9376090 T -0.025 rs676210 G -0.071 
rs1011731 G 0.015 rs4841132 A 0.057 rs13389219 C -0.037 
rs900399 A 0.019 rs2293889 T -0.015 rs2943641 T 0.033 
rs9816226 A 0.028 rs2954029 A -0.048 rs13326165 A 0.02 
rs12055786 C -0.021 rs4149268 C -0.015 rs9311651 A -0.021 
rs4871137 G -0.022 rs687621 A 0.043 rs645040 G 0.023 
rs10968576 A -0.017 rs2068888 G -0.016 rs442177 G 0.031 
rs7076938 C 0.019 rs7941030 T 0.014 rs13133548 G 0.014 
rs1037378 G -0.015 rs173539 C -0.033 rs9686661 C 0.042 
rs746463 C -0.017 rs9939224 T -0.023 rs459193 A 0.023 
rs7136716 A 0.021 rs7241918 G 0.02 rs998584 C 0.034 
rs10861661 A -0.017 rs6511720 G -0.21 rs2745353 C 0.02 
rs10483776 A -0.02 rs7412 C -0.54 rs4731702 C -0.027 
rs13379043 T 0.017 rs1132274 C 0.019 rs4841132 A -0.035 
rs8099014 C 0.015 rs4745 A -0.015 rs1801177 G 0.17 
rs2303108 T -0.015 rs976002 A 0.023 rs2954029 A -0.08 
rs12748152 C -0.043 rs13146272 C -0.015 rs2068888 G -0.032 
rs4847399 G -0.021 rs1016988 T -0.02 rs2167079 C -0.02 
rs12740374 G 0.045 rs351855 G -0.018 rs10892063 A -0.058 
rs12145743 T 0.017 rs3812594 G -0.018 rs1106766 C -0.03 
rs4650994 G -0.019 rs10885997 A 0.015 rs11057401 T -0.028 
rs1689800 A -0.025 rs1891110 G 0.021 rs1800588 C 0.047 
rs4846914 G 0.049 rs704 G 0.021 rs10468017 C 0.034 
rs676210 G 0.06 rs2239619 C 0.018 rs1421085 T 0.019 
rs2322659 T -0.019 rs67710536 A 0.028 rs173539 C -0.034 
rs13389219 C 0.035 rs9646133 G -0.019 rs9939224 T -0.034 
rs2943641 T -0.036 rs11080150 A -0.019 rs2925979 T -0.029 
rs2305637 C -0.032 rs2125345 T -0.024 rs2292642 C -0.02 
rs6762477 G 0.025 rs6062343 G -0.014 rs489693 C 0.015 
rs13326165 A -0.025 rs4809330 A -0.015 rs891088 A -0.017 
rs9311651 A 0.019 rs10903129 A 0.028 rs7255436 C -0.019 
rs645040 G -0.021 rs11206510 T -0.07 rs731839 G -0.015 
rs442177 G -0.018 rs2479409 G -0.047 rs7412 C 0.12 
rs13133548 G -0.017 rs505151 G -0.09 rs7679 T 0.053 
 16 
rs9686661 C -0.032 rs10889353 A -0.045 rs738322 A -0.02 
rs459193 A -0.02 rs7515577 C 0.03 rs6062343 G -0.018 
rs34525648 G -0.025 rs267733 A -0.025 rs10889353 A -0.077 
rs11755393 A -0.027 rs20558 T 0.015 rs541041 G 0.018 
rs2894342 C 0.017 rs2738755 C -0.015 rs1367117 G 0.023 
rs998584 C -0.026 rs541041 G 0.12 rs4245791 C -0.019 
rs35349911 C -0.017 rs1367117 G 0.11 rs6882076 T 0.038 
rs3756772 C 0.014 rs1801702 C -0.091 rs1564348 T 0.02 
rs2745353 C -0.023 rs4245791 C -0.072 rs7758229 G 0.018 
rs9376090 T -0.016 2:44066247 G -0.11 rs4722551 T -0.026 
rs2303361 T 0.025 rs11556157 A 0.025 rs4921914 C -0.035 
rs4917014 T 0.017 rs2030746 C 0.014 rs2081687 T -0.019 
rs4731702 C 0.033 rs2287623 G -0.021 rs1935 C -0.029 
rs3735080 C -0.017 rs887829 C -0.022 rs2255141 A 0.019 
rs4841132 A 0.1 rs2290159 G -0.021 rs2000999 G 0.021 
rs1801177 G -0.2 rs7640978 C -0.033 rs11871606 C 0.016 
rs2293889 T 0.029 rs2251219 T 0.016 rs58542926 C -0.12 
rs2954029 A 0.035 rs13315871 G -0.038 rs157580 G 0.047 
rs643531 C 0.053 rs3816873 T -0.017 rs492602 A 0.018 
rs4149268 C -0.034 rs12654264 A 0.066 rs738409 C -0.018 
rs2066714 T 0.043 rs4530754 G 0.017 rs3769823 A 0.017 
rs33918808 C 0.071 rs6882076 T 0.039 rs26008 T -0.028 
rs2230808 T 0.027 rs3757354 C -0.033 rs3803357 C -0.017 
rs687621 A 0.015 rs1264562 G 0.015 rs7946 C -0.016 
rs970548 A 0.026 rs13192471 T 0.038 rs2785990 C 0.016 
rs2068888 G 0.023 rs1055569 C 0.019 rs3947 G 0.024 
rs2167079 C 0.041 rs1564348 T 0.047 rs3927680 T -0.018 
rs10838738 A -0.032 rs7770628 C -0.031 rs7901016 T 0.042 
rs499974 C -0.026 rs7758229 G 0.016 rs797486 C 0.02 
rs10892063 A -0.018 rs12670798 T 0.033 rs7157785 G 0.023 
rs7941030 T 0.024 rs4722551 T 0.04 rs1077514 C 0.019 
rs7134375 C 0.021 rs4921914 C -0.022 rs6749689 T -0.016 
rs1106766 C 0.032 rs10102164 G 0.031 rs1049817 A -0.056 
rs7298565 G 0.03 rs2081687 T -0.028 rs1344642 G -0.015 
rs11057401 T 0.033 rs2737229 A -0.022 rs3748034 G 0.035 
rs838880 C -0.029 rs11136343 A 0.029 rs6831256 A 0.021 
rs1800588 C 0.12 rs3780181 A -0.037 rs16844401 G 0.03 
rs10468017 C 0.11 rs1935 C 0.018 rs1126673 C 0.017 
rs34317102 A 0.019 rs2255141 A -0.028 rs4311394 A 0.018 
rs1421085 T -0.022 rs10128711 T 0.025 rs3873379 T 0.028 
rs173539 C 0.23 rs11220462 G 0.043 rs2844480 C 0.023 
rs9939224 T 0.2 rs11057830 G 0.023 rs1057373 C 0.03 
rs5882 G -0.092 rs4942486 T -0.022 rs9271366 G 0.024 
 17 
rs2925979 T 0.041 rs8017377 G 0.023 rs78957773 C 0.052 
rs11869286 G 0.03 rs2000999 G 0.063 rs9472138 C -0.02 
rs2292642 C 0.028 rs34832584 G 0.02 rs4410790 T 0.015 
rs7241918 G 0.077 rs314253 T -0.02 rs2240466 G -0.12 
rs489693 C -0.019 rs11871606 C -0.027 rs38855 A -0.014 
rs891088 A 0.015 rs7188 A 0.048 rs11776767 G 0.022 
rs2277998 G 0.016 rs11669576 G 0.058 rs326 A -0.11 
rs7255436 C 0.029 rs11557092 T 0.024 rs7940646 T 0.016 
rs737337 T -0.058 rs58542926 C -0.1 rs174546 C 0.052 
rs6511720 G 0.024 rs157580 G 0.072 rs12801636 G -0.018 
rs731839 G 0.017 rs1800437 G -0.019 rs10047462 G -0.11 
rs2111504 T 0.02 rs492602 A 0.028 rs11820589 G 0.19 
rs7412 C 0.098 rs364585 A 0.019 rs3135507 C 0.085 
rs17695224 G -0.028 rs7261862 T -0.024 rs4149056 T 0.029 
rs386000 G 0.054 rs6029526 T 0.035 rs7200543 A 0.024 
rs12975366 T -0.029 rs6016373 A -0.024 rs12453522 A 0.021 
rs1132274 C -0.02 rs1053593 G -0.016 rs12947658 A -0.02 
rs6120757 C -0.017 rs738409 C -0.018 rs7248104 G -0.02 
rs7679 T -0.056 rs174546 C -0.053 rs6818397 T -0.021 
rs181362 C -0.028 rs2844529 G 0.018    
rs17738527 C -0.018 rs1169288 A 0.037    
rs4823006 A 0.014       
rs738322 A 0.02       
rs138457 T 0.017       
rs267733 A 0.021       
rs1367117 G -0.02       
rs2255141 A -0.027       
rs11871606 C -0.013       
rs157580 G -0.026       
rs2785990 C -0.015       
rs2240466 G 0.043       
rs326 A 0.11       
rs174546 C -0.042       
rs10047462 G 0.023       
rs11820589 G -0.087       
rs7200543 A -0.019       
rs1997243 A 0.026       
rs8060686 T 0.056       
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